errand along the way.

Two years ago, Paige said, the family's run to the store would have ended with Charlotte seizing on the ground amid broken eggs and terrified store managers dialing an ambulance.

"I do believe in a (Food and Drug Administration) clinical trial model," Figi said. "I just didn't have time to wait for that."

Remarkable progress

Interest in cannabidiol increased last week with the release of a scientific study abstract by Maa and Colorado Springs physician Dr. Margaret Gedde, who advises many of the epilepsy patients using it in Colorado.

Gedde and Maa's research showed parents of a handful of traumatic-seizure children reporting remarkable improvement on cannabidiol, or CBD. Eight of 11 families had "sharp reduction patterns in intractable seizures," Gedde said in an interview.

Maa is taking the results toof the heightened placebo effect in treatments involving children, when reports of progress depend on the view of parents — and even their family physicians — desperate for hope.

Justin and Annie Koozer uprooted their family from Tennessee to pursue cannabidiol in Colorado for their 2-year-old daughter, Piper. Yet Justin Koozer, too, worries about trying to see too much progress in Piper's intense seizures since she started taking the oil in late October.

Piper suffers from Aicardi syndrome, missing a crucial bundle of fibers attaching the brain hemispheres. After trying every other recommended drug with little impact, the most Koozer will say about CBD is that Piper has improvements that are "unquantifiable." She's having seizures, but fewer of them; she sleeps through many nights, a huge change.

"She can tolerate exercising